205 related articles for article (PubMed ID: 31882595)
1. Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice.
Isawa M; Karakawa A; Sakai N; Nishina S; Kuritani M; Chatani M; Negishi-Koga T; Sato M; Inoue M; Shimada Y; Takami M
Sci Rep; 2019 Dec; 9(1):19895. PubMed ID: 31882595
[TBL] [Abstract][Full Text] [Related]
2. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.
Williams DW; Lee C; Kim T; Yagita H; Wu H; Park S; Yang P; Liu H; Shi S; Shin KH; Kang MK; Park NH; Kim RH
Am J Pathol; 2014 Nov; 184(11):3084-93. PubMed ID: 25173134
[TBL] [Abstract][Full Text] [Related]
3. Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletons.
Vargas-Franco JW; Castaneda B; Gama A; Mueller CG; Heymann D; Rédini F; Lézot F
Biochem Pharmacol; 2019 Oct; 168():133-148. PubMed ID: 31260659
[TBL] [Abstract][Full Text] [Related]
4. Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: mouse strain disparities and synergic effect with zoledronic acid.
Lézot F; Chesneau J; Navet B; Gobin B; Amiaud J; Choi Y; Yagita H; Castaneda B; Berdal A; Mueller CG; Rédini F; Heymann D
Bone; 2015 Apr; 73():51-9. PubMed ID: 25532478
[TBL] [Abstract][Full Text] [Related]
5. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice.
Bargman R; Posham R; Boskey A; Carter E; DiCarlo E; Verdelis K; Raggio C; Pleshko N
Pediatr Res; 2012 Nov; 72(5):495-501. PubMed ID: 22926546
[TBL] [Abstract][Full Text] [Related]
6. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti-RANKL antibodies administered to pregnant mice on bone and tooth development in neonates.
Yamaguchi M; Takami M; Azetsu Y; Karakawa A; Chatani M; Funatsu T; Sakai N
J Oral Biosci; 2023 Jun; 65(2):186-194. PubMed ID: 36907379
[TBL] [Abstract][Full Text] [Related]
8. Effects of Anti-Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice.
Ikeda M; Karakawa A; Takizawa H; Azetsu Y; Sakai N; Chatani M; Suzuki N; Takami M
J Endod; 2022 May; 48(5):632-640. PubMed ID: 35181456
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption.
Walker CG; Dangaria S; Ito Y; Luan X; Diekwisch TG
Bone; 2010 Dec; 47(6):1020-9. PubMed ID: 20828639
[TBL] [Abstract][Full Text] [Related]
10. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats.
Bradaschia-Correa V; Moreira MM; Arana-Chavez VE
Cell Tissue Res; 2013 Jul; 353(1):79-86. PubMed ID: 23636419
[TBL] [Abstract][Full Text] [Related]
11. [Effects of post-natal inhibition of RANKL on molar eruption and root formation in C57BL/6 mice].
Gama A; Perea L; Yepes C; Betancur JJ; Vargas J; Amiaud J; Babajko S; Lezot F; Castaneda B
Orthod Fr; 2019 Mar; 90(1):55-63. PubMed ID: 30994449
[TBL] [Abstract][Full Text] [Related]
12. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis.
Kim HJ; Kim HJ; Choi Y; Bae MK; Hwang DS; Shin SH; Lee JY
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909508
[TBL] [Abstract][Full Text] [Related]
13. The effects of colony-stimulating factor-1 on tooth eruption in the toothless (osteopetrotic) rat in relation to the critical periods for bone resorption during tooth eruption.
Iizuka T; Cielinski M; Aukerman SL; Marks SC
Arch Oral Biol; 1992 Aug; 37(8):629-36. PubMed ID: 1514936
[TBL] [Abstract][Full Text] [Related]
14. Restoration of disturbed tooth eruption in osteopetrotic (op/op) mice by injection of macrophage colony-stimulating factor.
Niida S; Abe M; Suemune S; Yoshiko Y; Maeda N; Yamasaki A
Exp Anim; 1997 Apr; 46(2):95-101. PubMed ID: 9145288
[TBL] [Abstract][Full Text] [Related]
15. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic parathyroid extract on tooth eruption and dental tissues in osteopetrotic mice.
Schneider LC; Hollinshead MB; Manhold JH
Pharmacol Ther Dent; 1978; 3(1):31-7. PubMed ID: 273931
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
[TBL] [Abstract][Full Text] [Related]
18. [Effects of idiopathic hypoparathyroidism on tooth eruption of rats].
Zhao DF; Guan SY; Fan Y; Zheng LW
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):880-891. PubMed ID: 34496536
[No Abstract] [Full Text] [Related]
19. Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways.
Huang XL; Liu C; Shi XM; Cheng YT; Zhou Q; Li JP; Liao J
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34935053
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age-Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo.
Zhu M; Sun BH; Saar K; Simpson C; Troiano N; Dallas SL; Tiede-Lewis LM; Nevius E; Pereira JP; Weinstein RS; Tommasini SM; Insogna KL
J Bone Miner Res; 2016 Apr; 31(4):864-73. PubMed ID: 26496249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
